1. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
   Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
2. 5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues
   Irfan Cinar et al, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef